EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Calumenin, A Calcium‐Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With Therapeutic Application Promise

Parinaz Nasri Nasrabadi, Babak Jahangiri, Zahra Amiri, Forouzandeh Mahjoubi, Fatemeh Masoumi, Alireza Zomorodipour iD

FASEB BioAdvances · 2025-10 · 7 (10)

DOI: 10.1096/fba.2025-00106 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift FASEB BioAdvances, online erschienen am 13.10.2025. Verfasst von Parinaz Nasri Nasrabadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran Iran. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 286 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calumenin (CALU), a multifunctional E‐F‐hand protein of the CREC family involved in various cellular processes, is ubiquitously expressed in almost all human tissues, although its expression level is tissue‐specific. CALU plays an effective role in calcium (Ca) homeostasis throughout various Ca2 + ‐related processes, and its correlations with various ER‐related functions are evident. Due to its propensity to bind Ca, participation in calcium ion (Ca 2+ )‐dependent activities, major cellular processes, such as the production and maintenance of extracellular matrix, have been attributed to this multifaceted protein. In this regard, CALU's association with various normal calcification processes, as well as pathologic Ca deposits, is apparent. Additionally, its key role as a crossroads among various normal cellular processes and many inflammatory diseases and cancers is also evident. The important correlation of CALU with cancer‐related proteins through its regulatory role in γ‐carboxylation of known cancer‐related vitamin K‐dependent proteins has also been noted. The opposing and pleiotropic functions of the CALU isoforms might play balancing roles in establishing a state of equilibrium in the cell. Given the contradictory functions of CALU isoforms during cancer, the need for a balance between these isoforms, as well as the existence of mechanisms to regulate their ratio in normal cells, is speculated. The relationship between CALU and immune response, tumor‐infiltrating immune cells, and cancer patients' responsiveness to various cancer therapies is also described. In this regard, the involvement of the CALU isoform in response to cancer treatment and various immune pathways is discussed. This comprehensive review addresses the outstanding features and the latest findings on CALU's molecular aspects and diverse functions in various physiological processes and pathological conditions.

Schlagwörter

Stichwörter der Autor:innen

CALU isoformsCa depositionCa2+‐bindingER stresscalcium ion homeostasiscalumenincancerendoplasmic/sarcoplasmic reticulum‐related processesγ‐carboxylation

Autor:innen und Institutionen

  • Department of Molecular Medicine Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran Iran.
  • Department of Medical Genetics Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology Tehran Iran.

ORCID-Profile: Alireza Zomorodipour

Zitieren

APA

Nasrabadi, P. N., Jahangiri, B., Amiri, Z., Mahjoubi, F., Masoumi, F., & Zomorodipour, A. (2025). Calumenin, A Calcium‐Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With Therapeutic Application Promise. FASEB BioAdvances, 7(10). https://doi.org/10.1096/fba.2025-00106

Vancouver

Nasrabadi PN, Jahangiri B, Amiri Z, Mahjoubi F, Masoumi F, Zomorodipour A. Calumenin, A Calcium‐Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With Therapeutic Application Promise. FASEB BioAdvances. 2025;7(10). doi:10.1096/fba.2025-00106

BibTeX
@article{Nasrabadi2025,
  author = {Nasrabadi, Parinaz Nasri and Jahangiri, Babak and Amiri, Zahra and Mahjoubi, Forouzandeh and Masoumi, Fatemeh and Zomorodipour, Alireza},
  title = {Calumenin, A Calcium‐Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With Therapeutic Application Promise},
  journal = {FASEB BioAdvances},
  year = {2025},
  volume = {7},
  number = {10},
  doi = {10.1096/fba.2025-00106}
}
Kostenlos starten →